Autism Stem Cell Research Study – Greater Atlanta Integrative Pediatrics
GAIP Logo
Greater Atlanta
INTEGRATIVE
Pediatrics
← Home
🛡️ IRB Approved Study
📞 404-751-3693
🔬 Now Recruiting  ·  IRB Approved  ·  Ages 3+

AUTISMSTEM CELLRESEARCH STUDY

Helping Today for a Better Tomorrow

Greater Atlanta Integrative Pediatrics is enrolling individuals aged 3 and older with Autism Spectrum Disorder for an IRB-approved investigational research study — evaluating the safety and preliminary effects of stem cells combined with glutathione.

📞 Call to Learn More Am I Eligible? ↓
🧬 Stem Cells + Glutathione 📋 12-Month Study 🌎 Atlanta Metro & Nationwide 👶 Ages 3 to Adult
GAIP Autism Research Study - Roswell, Georgia

About the Study

GAIP Autism Spectrum Disorder Research Study

Greater Atlanta Integrative Pediatrics is conducting an IRB-approved research study evaluating the safety and preliminary effects of AdiaVita (umbilical cord blood-derived stem cells) combined with glutathione, compared to glutathione alone, in individuals aged 3 years and older with Autism Spectrum Disorder.

The primary endpoint is the change in participants' Autism Treatment Evaluation Checklist (ATEC) total scores from baseline to Month 6. Secondary endpoints include safety and tolerability, incidence of adverse events, and changes in quality of life and overall wellness.

This study builds on promising early clinical research, including Phase I and Phase II trials at Duke University, which demonstrated cord blood infusions to be safe and well-tolerated in individuals with ASD.

🛡️
IRB Approved · BeyondBound IRB Ethical oversight · Participant safety standards · Voluntary participation

Investigational Approach

🔬
Stem Cells
AdiaVita · Umbilical Cord Blood
+
🛡️
Glutathione
Antioxidant Support
⚕️ Safety & Wellness monitoring throughout all study phases
Study Title: GAIP Autism Spectrum Disorder Research Study
Sponsor: Greater Atlanta Integrative Pediatrics
Study Location: Roswell, Georgia (Atlanta Metro)
IRB (Oversight Board): BeyondBound IRB — Las Vegas, NV
Study Duration: 12 months per participant
Enrollment Goal: Approximately 100 participants
GAIP Autism Study participants - Roswell GA

Study Team

Meet the Investigators

Dr. Maia Gaither, MD
Principal Investigator

Dr. Maia Gaither, MD, FMCP-M

Dr. Maia Gaither brings over 25 years of pediatric experience, caring for children and young adults with both routine and complex needs — including those with special needs up to age 30. As a special needs mom herself, she understands what it's like when your instinct tells you something isn't right, even when you're told to "wait and see"

Amy Westmoreland, MSN, APRN
Sub-Investigator

Amy Westmoreland
MSN, APRN, FNP-C, FNP-BC

Operations Manager & Board-Certified Family Nurse Practitioner at GAIP. Ensures every family experience runs smoothly from first call to follow-up. She is a special needs mom who brings warmth and deep clinical expertise to every participant interaction.

Study Details

Research Purpose & Key Questions

🎯 Primary Purpose

Evaluate the safety and preliminary effects of AdiaVita (umbilical cord blood-derived stem cells) combined with glutathione vs. glutathione alone in individuals with ASD, as measured by the Autism Treatment Evaluation Checklist (ATEC) from baseline to Month 6.

🔬 Scientific Basis

ASD is associated with chronic low-grade neuroinflammation, oxidative stress, and immune dysregulation. Phase I & II trials at Duke University demonstrated cord blood infusions to be safe and well-tolerated with no serious infusion-related adverse events in individuals with ASD.

❓ Key Research Questions

Is AdiaVita + glutathione safe for individuals with ASD? Does this combination show preliminary changes in ASD symptoms vs. glutathione alone? What are the incidence and severity of any adverse events associated with each treatment arm?

📊 Study Design

Two-arm study with crossover option. Arm 1 receives AdiaVita + glutathione. Arm 2 receives glutathione alone, with the option to crossover to AdiaVita at Month 3. Active IV treatment for first 3 months, with follow-up continuing through Month 12.

1–4
Weeks
Screening before Baseline
3
Months
Active IV Treatment Phase
6
Months
Primary Endpoint (ATEC)
12
Months
Study Completion
~100
Participants
Enrollment Goal

Why Participate

Research. Hope. Possibilities.

🏥

Expert Clinical Team

Led by Dr. Maia Gaither, MD with 25+ years of integrative pediatric experience and a team that truly cares about every family.

🔒

IRB Oversight & Safety

Full IRB approval, continuous safety monitoring, and individualized care plans throughout the entire 12-month study.

🤝

Personalized Support

You're not just a participant — you're part of the GAIP family. Our team is with you every single step of the way.

💡

Advance ASD Research

Contribute to early-stage research that may improve our understanding of integrative approaches for Autism Spectrum Disorder.

Who Can Participate

Eligibility Criteria

✅ Inclusion Criteria

  • Age 3 years and older
  • Confirmed ASD diagnosis (DSM-5, supported by ADOS-2 or equivalent)
  • Parent/guardian willingness to consider experimental treatment
  • Ability to obtain required bloodwork
  • Ability to attend all scheduled visits

🚫 Exclusion Criteria

  • Severe allergies to study products
  • Significant uncontrolled medical conditions
  • Immunocompromised
  • History of malignancy
  • Unstable medication regimen within 30 days
  • Pregnancy or breastfeeding
  • Participation in another interventional trial within 30 days
⚠️ Informed written consent is required from all participants and/or parents/legal guardians prior to any study-specific procedures. Study products are investigational for ASD and are not FDA-approved to treat ASD. Benefits are not guaranteed. Participants may withdraw at any time.
👶🧒🧑🧓
3+
Years and Older
Parents with children and adults with a confirmed ASD diagnosis are encouraged to inquire
Located in the Atlanta Metro Area (Roswell, GA)
🌎 Open to Families Nationwide

How to Get Started

Simple Steps to Enroll

1

Call Us

Reach our team at 404-751-3693 to ask questions and express interest — no obligation.

2

Pre-Screening

Brief phone screen to assess whether you may be eligible for the study.

3

In-Person Consult

Meet with our team at GAIP to review full study details in a private, comfortable setting.

4

Consent & Enroll

Review and sign consent forms. You may take the form home first — no pressure, ever.

5

Begin Study

Start your 12-month journey with the full support of the GAIP care team.

Interested in Learning More?

Our care team is ready to answer every question and walk you through the enrollment process. No obligation — just a conversation about whether this study is right for your family.


📞 404-751-3693
Monday – Friday  ·  Greater Atlanta, GA  ·  Nationwide inquiries welcome
Research  ·  Hope  ·  Possibilities  ·  Together.

COMMON QUESTIONS

Frequently Asked Questions

💰 Is there a cost to participate? ＋
$12,000
Study Participation Fee
✅ Includes: all study visits, IV treatments, bloodwork, and assessments
✅ Stem cells + glutathione — no hidden fees
✅ Full GAIP study team support for 12 months

💡 Why this matters — the bigger picture:

  • Stem cell treatments typically range from $15,000–$25,000+ at private clinics — often without the oversight or research rigor of an IRB-approved study.
  • Many families have been traveling outside the United States — to Mexico, Panama, Germany, and other countries — spending $20,000 or more, with no long-term follow-up or safety monitoring.
  • This study offers a rare opportunity to access stem cell treatment right here in the US, at a fraction of the cost, under medical supervision, in an IRB-approved, scientifically monitored setting.
  • Located in Roswell, GA — in the North Atlanta metro area — this is one of the very few IRB-approved autism stem cell studies currently available in the United States.

What's NOT covered: Standard medical care outside the scope of this study (e.g., your regular pediatric visits) is not included. Participants are not compensated financially for participating.

Have questions about payment options or financial planning? Call us at 404-751-3693 — we're happy to talk through it with you.

🧬 What exactly is being studied? ＋

The study evaluates the safety and preliminary effects of umbilical cord blood-derived stem cells combined with glutathione (an antioxidant) compared to glutathione alone in individuals with ASD.

The primary measurement is the Autism Treatment Evaluation Checklist (ATEC) score from baseline to Month 6. The study lasts 12 months per participant with a goal of approximately 100 participants.

⚠️ These treatments are investigational and are not FDA-approved to treat ASD. Benefits are not guaranteed.

📅 How long does participation take? ＋

The full study lasts 12 months per participant. This includes:

  • Weeks 1–4: Screening and baseline assessments
  • Months 1–3: Active IV treatment phase with scheduled visits
  • Month 6: Primary endpoint evaluation (ATEC scores)
  • Month 12: Study completion and final follow-up

Each visit takes place at our Roswell, GA office. We work with your family's schedule and provide plenty of support throughout.

🏥 Is this study safe? Who is overseeing it? ＋

This study has been reviewed and approved by BeyondBound IRB (Las Vegas, NV), an independent Institutional Review Board that monitors research studies for participant safety and ethical standards.

Because this treatment is investigational, potential risks and side effects are not fully known. All participants receive informed consent before any procedures begin. You may withdraw at any time without penalty.

🔒 Is my family's information kept private? ＋

Yes. Your child's personal and health information is protected in accordance with HIPAA and applicable research privacy regulations. Study data is de-identified for analysis. You will receive full details in the informed consent form before any data is collected.

🚪 Can we withdraw from the study? ＋

Absolutely. Participation is 100% voluntary. You may withdraw at any time, for any reason, without penalty or effect on any other care you receive at GAIP. Simply notify the study team and we will guide you through the process.

🌐 Do we have to live in Atlanta to participate? ＋

The study visits take place at our office in Roswell, GA (Atlanta Metro area). We do welcome inquiries from families nationwide. Please call us at 404-751-3693 to discuss your situation — we will work with you to determine feasibility.

TAKE THE FIRST STEP

Express Your Interest

No commitment required. Just fill out the form below and our team will reach out within 48 hours to answer your questions and walk you through eligibility.

STUDY LOCATION

Visit Us in Roswell, GA

📍 Address

Greater Atlanta Integrative Pediatrics

1240 Upper Hembree Rd, Suite A
Roswell, GA 30076

🗺️ Get Directions

📞 Contact the Study Team

Phone: 404-751-3693

Email: intakes@gaipeds.com

Hours: Monday – Friday, 8:00 AM – 5:00 PM

Serving Roswell, Alpharetta, Sandy Springs, Johns Creek, Marietta, Cumming & the greater Atlanta metro area. Nationwide inquiries welcome.

⚖️ Important Research Disclosure

The purpose of this research study is to evaluate the safety and gather preliminary information about the effects of the investigational treatment.

Because this treatment is investigational, potential risks and side effects are not fully known.

Informed written consent is required from all participants and/or parents/legal guardians prior to any study-specific procedures. Study products are investigational for ASD and are not FDA-approved to treat ASD. Benefits are not guaranteed. Participants may withdraw at any time without penalty.

For questions about your rights as a research participant, please contact the Institutional Review Board (IRB): BeyondBound IRB — 3960 Howard Hughes Pkwy, Suite 500, Las Vegas, NV 89169  |  Phone: (702) 990-7099  |  Website: beyondbound.org

© Greater Atlanta Integrative Pediatrics · Sponsor of this IRB-Approved Study · gaipinc.com · 404-751-3693